澳股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

GENETIC SIGNATURES LTD

0.080

+0.0011.27%

成交量：7,262

成交额：581

市值：1,817.11万

市盈率：-1.30

高：0.080

开：0.080

低：0.080

收：0.079

52周最高：0.430

52周最低：0.051

股本：2.27亿

流通股本：1.88亿

量比：2.50

换手率：0.00%

股息：- -

股息率：- -

每股收益(TTM):-0.062

每股收益(LYR):-0.062

净资产收益率：-32.64%

总资产收益率：-17.27%

市净率：0.51

市盈率(LYR):-1.30

数据加载中...

总览公司新闻资讯公告

Genetic Signatures拟议合并将以发行GSS证券方式注资，不涉及现金对价

Genetic Signatures召开股东大会审议罢免董事决议

基因签名公司收到BCAL诊断公司请求，要求召开股东大会

BCAL诊断公司：要求罢免Michael Aicher，并提名Forrester与Melki进入GSS董事会

遗传特征公司要求BCAL诊断澄清其在GSS的持股及关联方详情

基因标记公司：合并集团有望凭借精简成本基础与潜在加速增长受益

BCAL Diagnostics将收购Genetic Signatures股份

GENETIC SIGNATURES LTD澄清：未收到亦未向ASX提交与Bcal公告相关的股份收购重大持股人通知

GENETIC SIGNATURES LTD表示无法对BCAL意图置评，仅以BCAL公告内容为准

GENETIC SIGNATURES LTD确认对先前公告中提及的股份收购提议事先不知情

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/hans/stock/GSS.AU/news"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"GSS.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"GSS.AU\",,,,,undefined,":{"symbol":"GSS.AU","market":"AU","secType":"STK","nameCN":"GENETIC SIGNATURES LTD","latestPrice":0.08,"timestamp":1791846215542,"preClose":0.079,"halted":0,"volume":7262,"delay":0,"changeRate":0.012658227848101278,"nameEN":"GENETIC SIGNATURES LTD","floatShares":188016272,"shares":227138828,"eps":-0.0617,"marketStatus":"交易中","change":0.001,"latestTime":"10-13 10:11:53 AEDT","open":0.08,"high":0.08,"low":0.08,"amount":581,"amplitude":0,"askPrice":0.084,"askSize":5000,"bidPrice":0.08,"bidSize":55738,"shortable":3,"etf":0,"ttmEps":-0.0617,"tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1791867600000},"marketStatusCode":2,"adr":0,"exchange":"ASX","adjPreClose":0.079,"openAndCloseTimeList":[[1791846000000,1791867600000]],"volumeRatio":2.49591,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"GSS.AU","preClose":0.079,"auctionPrice":0.08,"auctionVolume":7262,"auctionTime":1791845944917,"referenceTime":1791455403091,"auction":1,"marketStatus":"盘前竞价","timestamp":1791845944917}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"GSS.AU\",,,,,undefined,":{"symbol":"GSS.AU","floatShares":188016272,"roa":"-17.27%","roe":"-32.64%","lyrEps":-0.0617,"volumeRatio":2.49591,"shares":227138828,"dividePrice":0,"high":0.08,"amplitude":0,"preClose":0.079,"low":0.08,"week52Low":0.051,"pbRate":"0.51","psRate":"0.94","week52High":0.43,"institutionHeld":0,"latestPrice":0.08,"committee":0.835358,"eps":-0.0617,"divideRate":0,"volume":7262,"delay":0,"ttmEps":-0.0617,"open":0.08,"prevYearClose":0.25,"prevWeekClose":0.084,"prevMonthClose":0.078,"prevQuarterClose":0.078,"fiveDayClose":0.079,"twentyDayClose":0.073,"sixtyDayClose":0.066,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/GSS.AU\",params:#limit:5,,,undefined,":[{"date":"2026-08-25","symbol":"GSS.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1787616000000,"name":null,"time":"","dateTimestamp":1787580000000,"actualEps":null},{"date":"2026-02-26","symbol":"GSS.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1772060400000,"name":null,"time":"","dateTimestamp":1772024400000,"actualEps":null},{"date":"2025-08-25","symbol":"GSS.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756080000000,"name":null,"time":"","dateTimestamp":1756044000000,"actualEps":null},{"date":"2025-02-26","symbol":"GSS.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1740524400000,"name":null,"time":"","dateTimestamp":1740488400000,"actualEps":null},{"market":"AU","date":"2023-12-27","symbol":"GSS.AU","defaultRemindTime":1703631600000,"type":"split","dateTimestamp":1703595600000,"forFactor":976761,"toFactor":1000000,"ratio":0.9767610000000001}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"GSS.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"GSS.AU\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1114429036","title":"Genetic Signatures拟议合并将以发行GSS证券方式注资，不涉及现金对价","url":"https://stock-news.laohu8.com/highlight/detail?id=1114429036","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1114429036?lang=zh_cn&edition=fundamental","pubTime":"2026-09-22 07:28","pubTimestamp":1790033293,"startTime":"0","endTime":"0","summary":"Genetic Signatures——这项拟议中的合并案，其注资途径已明确：通过发行GSS证券来实现，而非采用现金对价方式。这一安排意味着，交易双方在资金结算上将完全绕开现金流的直接转移，转而依托股权交换的结构性框架推进合并进程。总的来说，这是一次结构设计上颇为巧妙的资本运作，其实际成效将依赖于市场对GSS证券的接受度及合并后实体的协同效应。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7124","BK7048","GSS.AU","MAP.AU","BK7501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1188205108","title":"Genetic Signatures召开股东大会 审议罢免董事决议","url":"https://stock-news.laohu8.com/highlight/detail?id=1188205108","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1188205108?lang=zh_cn&edition=fundamental","pubTime":"2026-09-17 07:59","pubTimestamp":1789603172,"startTime":"0","endTime":"0","summary":"Genetic Signatures公司宣布，将召开一次股东大会，专门审议一项关于罢免某位董事的决议案。\n此次会议的核心议题，聚焦于是否解除该名董事的职务。公司方面已就此发出正式通知，提请全体股东共同商议并作出决定。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GSS.AU","BK7048","BK7501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1177770479","title":"基因签名公司收到BCAL诊断公司请求，要求召开股东大会","url":"https://stock-news.laohu8.com/highlight/detail?id=1177770479","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1177770479?lang=zh_cn&edition=fundamental","pubTime":"2026-09-17 07:51","pubTimestamp":1789602669,"startTime":"0","endTime":"0","summary":"基因签名公司（Genetic Signatures）已收到来自BCAL诊断公司的正式请求，要求其董事召开并安排股东大会。这一动态标志着双方关系的重大转折，也预示着可能发生治理层面的关键变动。据悉，BCAL诊断公司依据相关法规条款，向基因签名公司的董事层发出了这一正式提议，旨在推动股东层面的直接对话和决策。此举在资本市场引发广泛关注，投资者正密切留意后续进展，评估此次会议可能对基因签名公司治理结构及战略方向带来的潜在影响。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7048","BK7501","GSS.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1173556031","title":"BCAL诊断公司：要求罢免Michael Aicher，并提名Forrester与Melki进入GSS董事会","url":"https://stock-news.laohu8.com/highlight/detail?id=1173556031","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1173556031?lang=zh_cn&edition=fundamental","pubTime":"2026-09-03 10:42","pubTimestamp":1788403333,"startTime":"0","endTime":"0","summary":"BCAL诊断有限公司已正式提出动议，要求将Michael Aicher从Genetic Signatures Ltd董事会中罢免。与此同时，该公司还力荐Forrester及Melki两位候选人，以期他们能够顺利加入GSS董事会。这一人事调整举措，无疑为GSS公司的治理结构投下了一枚重磅炸弹。BCAL方面显然希望通过此番运作，重塑董事会的权力格局，注入新鲜血液。BCAL此举的深层动因，以及新任董事若顺利上位后将带来怎样的治理新风，均有待市场的进一步观察与解读。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7501","GSS.AU","BK7048","BK7067","BDX.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1115211142","title":"遗传特征公司要求BCAL诊断澄清其在GSS的持股及关联方详情","url":"https://stock-news.laohu8.com/highlight/detail?id=1115211142","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1115211142?lang=zh_cn&edition=fundamental","pubTime":"2026-09-03 07:39","pubTimestamp":1788392350,"startTime":"0","endTime":"0","summary":"遗传特征有限公司（Genetic Signatures Ltd, GSS.AU）已正式向BCAL诊断有限公司（BCAL Diagnostics Ltd, BDX.AU）发出请求，要求后者就其在该公司的持股情况以及关联方关系提供更为详尽的说明。\n据悉，此项请求涉及BCAL诊断在遗传特征公司中的股东身份及相关联方细节，但具体交易背景及可能引发的后续影响尚未对外披露。市场参与人士正密切关注事态发展，以评估这一动向可能对两家澳大利亚医疗诊断领域企业带来的潜在影响。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7048","BK7067","BK7501","GSS.AU","BDX.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1125560310","title":"基因标记公司：合并集团有望凭借精简成本基础与潜在加速增长受益","url":"https://stock-news.laohu8.com/highlight/detail?id=1125560310","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1125560310?lang=zh_cn&edition=fundamental","pubTime":"2026-08-26 07:36","pubTimestamp":1787700997,"startTime":"0","endTime":"0","summary":"基因标记公司——合并后的集团预计将从精简的成本结构中获益，并可能迎来增长加速的契机。市场分析人士指出，成本基础的收窄不仅有助于提升盈利能力，更为潜在的扩张机遇创造了有利条件。值得注意的是，合并后实体的协同效应有望在中期内逐步显现，从而推动业绩增长轨迹向上修正。简而言之，这一变革性举措预示着集团将步入一个更加精简、高效且具备增长动能的新阶段。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7048","BK7124","GSS.AU","BK7501","MAP.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1182337442","title":"BCAL Diagnostics将收购Genetic Signatures股份","url":"https://stock-news.laohu8.com/highlight/detail?id=1182337442","media":"投资观察","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1182337442?lang=zh_cn&edition=fundamental","pubTime":"2026-07-07 16:48","pubTimestamp":1783414100,"startTime":"0","endTime":"0","summary":"7月2日——BCAL Diagnostics有限公司宣布，将收购GENETIC SIGNATURES有限公司的股份。具体而言，BCAL将以139万澳元的价格，收购GENETIC SIGNATURES公司10.2%的股权。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7048","GSS.AU","BDX.AU","BK7067","BK7501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1183625175","title":"GENETIC SIGNATURES LTD澄清：未收到亦未向ASX提交与Bcal公告相关的股份收购重大持股人通知","url":"https://stock-news.laohu8.com/highlight/detail?id=1183625175","media":"美股速递","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1183625175?lang=zh_cn&edition=fundamental","pubTime":"2026-07-02 12:45","pubTimestamp":1782967543,"startTime":"0","endTime":"0","summary":"GENETIC SIGNATURES LTD发布澄清声明，表示公司并未收到，也未向澳大利亚证券交易所（ASX）提交任何与Bcal公告中所提及的股份收购相关的重大持股人通知。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7501","GSS.AU","BK7048"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1152360294","title":"GENETIC SIGNATURES LTD表示无法对BCAL意图置评，仅以BCAL公告内容为准","url":"https://stock-news.laohu8.com/highlight/detail?id=1152360294","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1152360294?lang=zh_cn&edition=fundamental","pubTime":"2026-07-02 12:42","pubTimestamp":1782967368,"startTime":"0","endTime":"0","summary":"GENETIC SIGNATURES LTD明确指出，对于BCAL的意图，除BCAL自身公告中的声明外，公司无法提供任何进一步评论。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GSS.AU","BK7501","BK7048"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1197336969","title":"GENETIC SIGNATURES LTD确认对先前公告中提及的股份收购提议事先不知情","url":"https://stock-news.laohu8.com/highlight/detail?id=1197336969","media":"美股速递","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1197336969?lang=zh_cn&edition=fundamental","pubTime":"2026-07-02 12:42","pubTimestamp":1782967368,"startTime":"0","endTime":"0","summary":"GENETIC SIGNATURES LTD已确认，对于先前公告中所提及的股份收购提议，公司方面事先并不知情。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7501","GSS.AU","BK7048"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":10,"code":"91000000","status":"200"}]}}